Amniotic Products Market 2031 | Size, Share, Analysis, Growth by Segmentation and Forecast
Amniotic Products Market Overview:
The global amniotic
products market is projected to grow at a CAGR of approximately 8%,
reaching nearly USD 1 billion by 2031. This growth is driven by the rising
number of amniotic membrane transplantations, expanding research in stem cell
and regenerative medicine, increasing awareness of the clinical benefits of
amniotic membrane therapies, a growing incidence of traumatic wounds, and the
wider adoption of dehydrated amniotic membranes.
Download Sample PDF Copy: https://meditechinsights.com/amniotic-products-market/request-sample/
Amniotic-derived products—including amniotic membrane
and amniotic fluid—represent a subtype of orthobiologics and are increasingly
recognized as promising treatment options for joint inflammation, tissue
repair, and healing. The amniotic membrane (AM) is a thin sac that surrounds
the fetus and contains amniotic fluid. Currently, all amniotic, placental, and
umbilical tissue-based products are classified by the U.S. FDA as human tissue
products without living cells.
Initially, amniotic membranes were used primarily for
treating skin conditions such as burns, ulcers, and chronic wounds. Owing to
their unique biological properties, their applications have expanded
significantly and now include corneal surface reconstruction, retinal
detachment repair, limbal stem cell regeneration, plantar fasciitis, ligament
and tendon healing, spinal disorders, cartilage repair, and osteoarthritis
management. Cryopreserved and lyophilized amniotic membranes are the most
commonly used forms in clinical practice.
Growing Adoption of Amniotic-Based
Products in Wound Healing
Amniotic membranes are composed of structural collagen,
extracellular matrix components, and biologically active elements that work
synergistically to regulate wound healing. Chronic non-healing wounds are often
characterized by prolonged inflammation, which disrupts the normal healing
cascade and leads to reduced growth factor activity and degradation of the
extracellular matrix. Amniotic membranes help restore this balance by
delivering essential growth factors and supporting tissue regeneration. In
diabetic and immunocompromised patients—where natural wound-healing mechanisms
are impaired—placental-based products have emerged as a critical therapeutic
option, significantly improving healing outcomes.
Rising Role of Amniotic Membranes in
Regenerative Medicine
Regenerative medicine is a rapidly advancing
interdisciplinary field focused on repairing, replacing, or regenerating
damaged tissues and organs. Amniotic membrane products play a vital role in
this domain due to their high biocompatibility, scaffold-like structure, and rich
content of stem cells and growth factors. Additionally, their high entrapment
capacity enables effective drug delivery, positioning them as functional
nano-reservoirs. These properties support a wide range of applications,
including fetal tracheal reconstruction, diaphragm repair, bone grafting, heart
valve repair, plantar fasciitis treatment, osteoarthritis therapy, dermal
fillers, spinal cord regeneration, ophthalmic disorders, and skin
repair—further fueling market demand.
Download Sample PDF Copy: https://meditechinsights.com/amniotic-products-market/request-sample/
“Amniotic-based products are rapidly emerging across
multiple medical fields. Significant advances in biology and engineering have
expanded our understanding of tissue engineering and biomaterials, paving the
way for innovative therapies that can substantially reduce disease burden.”
— Senior Director, Data Sciences & Quantitative Biology, U.S.-based Amniotic
Products Company
North America Dominates Market
Adoption
Geographically, North America accounts for the largest
share of the global amniotic products market, followed by Europe. Factors
contributing to regional dominance include robust research activity, advanced
healthcare infrastructure, widespread clinical adoption of amniotic membranes,
increased awareness of amniotic transplantation, and the strong presence of
leading market players.
Competitive Landscape
Key companies operating in the amniotic products market
include MiMedx, Smith & Nephew, Organogenesis Inc., Integra LifeSciences,
Applied Biologics, Katena Products, Lucina BioSciences, Next Biosciences, Skye
Biologics Holdings, Surgenex, Ventris Medical, Vivex Biologics, StimLabs,
Amniotics AB, LifeCell International, NuVision Biotherapies, Genesis Biologics,
Amnio Technology, Amnicell Corporation, AlloSource, Celularity, TissueTech,
Orthofix Medical, Merakris Therapeutics, and Human Regenerative Technologies,
among others.
Browse Report: https://meditechinsights.com/amniotic-products-market/
Organic Growth Strategies Drive Market
Expansion
Market players are increasingly focusing on organic
growth strategies such as product launches, clinical advancements, and funding
initiatives to strengthen their market position. Notable developments include:
- May 2022: MiMedx Group, Inc. received a USD 4.6 million
U.S. Department of Defense award to evaluate PURION®-processed dehydrated
human amnion chorion membrane (DHACM) for advanced wound and burn care.
- July 2021: Amniotics AB raised USD 6.1 million through its
Nasdaq First North Growth Market listing to advance its preclinical stem
cell therapy portfolio derived from amniotic fluid.
- January 2021: Organogenesis Inc. received U.S. FDA approval to
launch ReNu®, a cryopreserved amniotic suspension allograft for managing
symptoms associated with knee osteoarthritis.
Overall, the amniotic products market is poised for
sustained growth, supported by ongoing research advancements, rising cases of
burn injuries and traumatic wounds, increasing surgical volumes in cosmetics,
ophthalmology, and orthopedics, greater awareness of advanced wound care
solutions, and strong funding from private investors, governments, and
strategic partnerships.
Related Report:
HPV Testing and PAP Test Market - https://www.pharmiweb.com/press-release/2025-12-18/hpv-testing-and-pap-test-market-share-size-growth-forecast-till-2030
Cellular Health Screening Market - https://www.pharmiweb.com/press-release/2025-12-18/cellular-health-screening-market-2030-analysis-size-share-growth-trends-and-forecast
Hematology Market - https://www.pharmiweb.com/press-release/2025-12-18/hematology-market-outlook-2030-industry-trends-and-competitive-analysis
Long-Term Care Software Market - https://www.pharmiweb.com/press-release/2025-12-18/long-term-care-software-market-demand-for-evidence-based-medicine-and-research-updates
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply
side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment